Musculoskeletal pain: prescription of NSAID and weak opioid by primary health care physicians in Sweden 2004-2008 - a retrospective patient record review
- PMID: 21197316
- PMCID: PMC3004648
- DOI: 10.2147/jpr.s12052
Musculoskeletal pain: prescription of NSAID and weak opioid by primary health care physicians in Sweden 2004-2008 - a retrospective patient record review
Abstract
Purpose: To study the prescription of oral analgesics for musculoskeletal pain by primary care physicians over a 5-year period in Sweden.
Design: A retrospective automatic database review of patient records at four primary health care centers. All prescriptions of NSAIDs, weak opioids, and coprescriptions of gastroprotecting medications to patients with musculoskeletal were retrieved for the period January 1, 2004 to November 11, 2008.
Results: A total of 27,067 prescriptions prescribed to 23,457 patients with musculoskeletal pain were analyzed. Of all prescriptions, NSAIDs were the most commonly prescribed analgesic comprising 79%, tramadol was the second most commonly prescribed analgesic comprising 9%, codeine the third most (7%), and dextropropoxyphene the fourth (5%). The proportion of NSAIDs and weak opioids and the proportion of the different weak opioids prescribed showed no change over time. The proportion of nonselective and selective NSAIDs prescribed changed; Coxib prescriptions decreased from 9% to 4% of all analgesics prescribed in 2004-2007 with no change in 2008.
Conclusion: NSAIDs were found to be the dominant class of analgesic prescribed by primary care physicians to patients diagnosed as musculoskeletal pain. No change was observed in the proportion of NSAID and weak opioid prescription over the period studied. Prescription of selective Coxibs decreased and was less than 4% in 2008. The impact on gastrointestinal and cardiovascular adverse effects associated with the extensive prescription of NSAIDS for musculoskeletal pain warrants further analysis.
Keywords: codeine; dextropropoxyphene; nonsteroidal anti-inflammatory drugs; pattern of use; pharmacoepidemiology; primary care; tramadol.
Figures
Similar articles
-
Effect of the market withdrawal of dextropropoxyphene on use of other prescribed analgesics.Scand J Pain. 2018 Oct 25;18(4):667-674. doi: 10.1515/sjpain-2018-0103. Scand J Pain. 2018. PMID: 30145581
-
Pain medication management of musculoskeletal conditions at first presentation in primary care: analysis of routinely collected medical record data.BMC Musculoskelet Disord. 2014 Dec 10;15:418. doi: 10.1186/1471-2474-15-418. BMC Musculoskelet Disord. 2014. PMID: 25492581 Free PMC article.
-
Evaluation of prescription pattern of analgesic use among ambulatory elderly in South-Western Nigeria.Ann Afr Med. 2020 Apr-Jun;19(2):131-136. doi: 10.4103/aam.aam_57_19. Ann Afr Med. 2020. PMID: 32499470 Free PMC article.
-
"Weak" opioid analgesics. Codeine, dihydrocodeine and tramadol: no less risky than morphine.Prescrire Int. 2016 Feb;25(168):45-50. Prescrire Int. 2016. PMID: 27042732 Review.
-
Tramadol in musculoskeletal pain--a survey.Clin Rheumatol. 2002 Feb;21 Suppl 1:S9-11; discussion S11-2. doi: 10.1007/s100670200030. Clin Rheumatol. 2002. PMID: 11954901 Review.
Cited by
-
Prescription pattern and prevalence of potentially inappropriate medications among elderly patients in a Nigerian rural tertiary hospital.Ther Clin Risk Manag. 2013;9:115-20. doi: 10.2147/TCRM.S40120. Epub 2013 Mar 13. Ther Clin Risk Manag. 2013. PMID: 23516122 Free PMC article.
-
Musculoskeletal Pain Management and Thermotherapy: An Exploratory Analysis of Italian Physicians' Attitude, Beliefs, and Prescribing Habits.J Pain Res. 2023 May 11;16:1547-1557. doi: 10.2147/JPR.S401550. eCollection 2023. J Pain Res. 2023. PMID: 37197390 Free PMC article.
-
Prevalence, diagnostics and management of musculoskeletal disorders in primary health care in Sweden - an investigation of 2000 randomly selected patient records.J Eval Clin Pract. 2017 Apr;23(2):325-332. doi: 10.1111/jep.12614. Epub 2016 Aug 19. J Eval Clin Pract. 2017. PMID: 27538347 Free PMC article.
-
Frequency and Associations of Prescription Nonsteroidal Anti-inflammatory Drug Use Among Patients With a Musculoskeletal Disorder and Hypertension, Heart Failure, or Chronic Kidney Disease.JAMA Intern Med. 2018 Nov 1;178(11):1516-1525. doi: 10.1001/jamainternmed.2018.4273. JAMA Intern Med. 2018. PMID: 30304456 Free PMC article.
-
Ischaemic cardiovascular risk and prescription of non-steroidal anti-inflammatory drugs for musculoskeletal complaints.Scand J Prim Health Care. 2014 Jun;32(2):90-8. doi: 10.3109/02813432.2014.929810. Epub 2014 Jun 15. Scand J Prim Health Care. 2014. PMID: 24931511 Free PMC article.
References
-
- Hasselström J, Liu-Palmgren J, Rasjö-Wrååk G. Prevalence of pain in general practice. Eur J Pain. 2002;6(5):375–385. - PubMed
-
- Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage. 2007;15(9):981–1000. - PubMed
-
- Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16(2):137–162. - PubMed
-
- Weaver AL. Current and emerging treatments for mild/moderate acute ambulatory pain. Am J Ther. 2008;15(Suppl 10):S12–S16. - PubMed
LinkOut - more resources
Full Text Sources